The formulation of carvedilol transdermal patch with resin gum as rate control

Authors

  • Kori Yati DEP. FARMASI Universitas Muhammadiyah Prom. DR. HAMKA
  • Septiana Tri Pamungkas DEP. FARMASI Universitas Muhammadiyah Prom. DR. HAMKA

DOI:

https://doi.org/10.12928/pharmaciana.v8i1.9308

Keywords:

carvedilol, rate control, reservoir, resin gum, transdermal patch

Abstract

Carvedilol is widely prescribed for long-term hypertension treatment. It is rapidly absorbable by oral administration, but its bioavailability is merely about 20% in humans. Drug delivery is therefore imperative to overcome this weakness. One form of transdermal drug delivery system is a patch. Transdermal patch is composed of various systems, for instance, a reservoir that uses a rate control layer to manage the rate of drug release. This research aimed to observe the effect of using resin gum as the control of drug release rate on the physical characteristics and release of carvedilol in a transdermal patch. The patches were prepared in 5 formulas with different quantities of resin gum, namely 50, 100, 150, 200, and 250 mg. Afterward, they were evaluated physically, and their dissolution and diffusion rates were analyzed. The results showed that resin gum with concentrations of 150 mg and 200 mg was physically qualified for rate control. Besides, the results of dissolution and diffusion tests revealed that transdermal patches with 150 mg of resin gum exhibited the best drug release and penetration.

References

Ahad, A., Al-Jenoobi, F., Al-Mohizea, A.M., Akhtar, N., Raish, M., & Aqil, M., 2014, Systemic Delivery of β-blockers via Transdermal Route for Hypertension, Saudi Pharmaceutical Journal.

Alexander, A., Dwivedi, S., Ajazuddin, Giri T.K., Saraf, S., & Tripathi D.K., 2012, Approaches for Breaking the Barriers of Drug Permeation Through Transdermal Drug Delivery, Journal of Controlled Release, 164(1), 26–40.

Coppen J.J.W., 1995, Non-Wood Forest Products 6 : Gums, Resins and Latexes of Plant Origin. Food and Agriculture Organization of The United Nations, Rome, 65.

Mundada A.S., & Avari J.G., 2009, Permeability studies of Damar Batu Free Films for Transdermal Application, Chemical Industry and Chemical Engineering Quarterly, 15(2), 83–88.

Patel H., Bhimani B., & Patel G., 2012, Transdermal Drug Delivery System As Prominent Dosage Forms for the Highly Lipophilic Drugs, International Journal of Pharmaceutical Bio-Science, 1(3), 42–65.

Premjeet S., Bilandi A., Sahil K., & Akanksha M., 2011, Transdermal Drug Delivery System (Patches ), Applications In Present Scenario, International Journal Of Research In Pharmacy And Chemistry, 1(4), 1139–1151.

Saroha K., Yadav B., Sharma B., 2011, Transdermal Patch : A Discrete Dosage Form. International, Journal of Current Pharmaceutical Research, 3(3), 98-108.

Sonjoy M., Thimmasetty, Ratan & Kilarimath, 2011, Formulation and Evaluation of Carvedilol Transdermal Patches, International Research Journal of Pharmacy, 2(1), 237-248.

Downloads

Published

2018-06-02

Issue

Vol. 8 No. 1 (2018): Pharmaciana

Section

Pharmaceutics and Pharmaceutical Technology

License

Authors who publish with Pharmaciana agree to the following terms:

  1. Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. 
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.